Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 4
1987 1
1988 1
1989 1
1990 1
1992 1
1993 1
1994 3
1995 1
1996 4
1997 3
1998 6
1999 4
2000 1
2001 2
2002 10
2003 11
2004 12
2005 5
2006 8
2007 8
2008 6
2009 8
2010 10
2011 8
2012 15
2013 10
2014 10
2015 11
2016 9
2017 7
2018 9
2019 9
2020 11
2021 10
2022 9
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

214 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
Regulation of Stemness in Carcinoma Cells.
Hao J, Unternaehrer J, Cui X, Cheng N, Oji Y. Hao J, et al. Among authors: oji y. Stem Cells Int. 2017;2017:7681769. doi: 10.1155/2017/7681769. Epub 2017 Jul 27. Stem Cells Int. 2017. PMID: 28819365 Free PMC article. No abstract available.
Imaging Assessment of Tumor Response in the Era of Immunotherapy.
Nakata J, Isohashi K, Oka Y, Nakajima H, Morimoto S, Fujiki F, Oji Y, Tsuboi A, Kumanogoh A, Hashimoto N, Hatazawa J, Sugiyama H. Nakata J, et al. Among authors: oji y. Diagnostics (Basel). 2021 Jun 5;11(6):1041. doi: 10.3390/diagnostics11061041. Diagnostics (Basel). 2021. PMID: 34198874 Free PMC article. Review.
Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain.
Hasegawa K, Ikeda S, Yaga M, Watanabe K, Urakawa R, Iehara A, Iwai M, Hashiguchi S, Morimoto S, Fujiki F, Nakajima H, Nakata J, Nishida S, Tsuboi A, Oka Y, Yoshihara S, Manabe M, Ichihara H, Mugitani A, Aoyama Y, Nakao T, Hirose A, Hino M, Ueda S, Takenaka K, Masuko T, Akashi K, Maruno T, Uchiyama S, Takamatsu S, Wada N, Morii E, Nagamori S, Motooka D, Kanai Y, Oji Y, Nakagawa T, Kijima N, Kishima H, Ikeda A, Ogino T, Shintani Y, Kubo T, Mihara E, Yusa K, Sugiyama H, Takagi J, Miyoshi E, Kumanogoh A, Hosen N. Hasegawa K, et al. Among authors: oji y. Sci Transl Med. 2022 Feb 16;14(632):eaax7706. doi: 10.1126/scitranslmed.aax7706. Epub 2022 Feb 16. Sci Transl Med. 2022. PMID: 35171652
Neuroimaging Pearls from the MDS Congress Video Challenge. Part 2: Acquired Disorders.
Fearon C, Rawal S, Olszewska D, Alcaide-Leon P, Kern DS, Sharma S, Jaiswal SK, Murthy JMK, Ha AD, Schwartz RS, Fung VSC, Spears C, Tholanikunnel T, Almeida L, Hatano T, Oji Y, Hattori N, Shubham S, Kumar H, Bhidayasiri R, Laohathai C, Lang AE. Fearon C, et al. Among authors: oji y. Mov Disord Clin Pract. 2022 Feb 3;9(3):311-325. doi: 10.1002/mdc3.13415. eCollection 2022 Apr. Mov Disord Clin Pract. 2022. PMID: 35402651 Free PMC article. Review.
WT1 peptide vaccine for the treatment of cancer.
Oka Y, Tsuboi A, Oji Y, Kawase I, Sugiyama H. Oka Y, et al. Among authors: oji y. Curr Opin Immunol. 2008 Apr;20(2):211-20. doi: 10.1016/j.coi.2008.04.009. Epub 2008 May 24. Curr Opin Immunol. 2008. PMID: 18502632 Review.
214 results